
Fenabrate 160mg Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Fenofibrate (160mg)
Overview Fenabrate 160mg Tablet
Gemfibrozil 160mg tablets effectively manage elevated cholesterol. This medication lowers triglycerides and low-density lipoprotein ("bad") cholesterol (LDL), simultaneously increasing high-density lipoprotein ("good") cholesterol (HDL). Reduced cholesterol levels lessen the risk of cardiovascular events like heart attacks and strokes. Adhere strictly to your physician's prescribed dosage and regimen for Gemfibrozil 160mg tablets. It can be taken with meals at any time, but consistency is key. High cholesterol often presents without symptoms; discontinuation may exacerbate the condition, raising cholesterol and increasing heart disease risk. Regular cholesterol monitoring is crucial. This medication is part of a comprehensive treatment plan that includes a balanced diet, regular physical activity, smoking cessation, responsible alcohol consumption, and weight management. Maintain a normal diet, minimizing high-fat foods. Common side effects include nausea, stomach upset, diarrhea, and vomiting. Inform your doctor of all other medications before starting Gemfibrozil. Exercise caution if you have kidney or liver problems. Pregnant or breastfeeding individuals should consult their doctor before use.
Uses of Fenabrate 160mg Tablet
Elevated cholesterol and triglyceride levels
Major Benefits of Fenabrate 160mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Fenabrate 160mg Tablet with a meal.
Common Side effects of Fenabrate 160mg Tablet:
- Abdominal pain
- Diarrhea
- Nausea
- Headache
- Flatulence
- Vomiting
- Increased liver enzymes
- Increased creatine phosphokinase (CPK) level in blood
- Back pain
- Inflammation of the nose
How to use Fenabrate 160mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 160mg Fenabrate tablet should be administered with a meal.
How Fenabrate 160mg Tablet works:
Fenofibric acid 160mg tablets reduce high lipid levels. This medication decreases triglycerides and low-density lipoprotein (LDL) cholesterol, concurrently increasing high-density lipoprotein (HDL) cholesterol.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Fenabrate 160mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Fenabrate 160mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Fenabrate 160mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Fenabrate 160mg tablets.
KidneyCAUTION
Patients with kidney impairment should use 160mg Fenabrate tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Fenabrate 160mg tablets are contraindicated in individuals with severely compromised kidney function.
LiverUNSAFE
Patients with liver disease should not take Fenabrate 160mg tablets; this medication poses a significant risk to them. Individuals with severe liver impairment are strongly advised against its use. Medical advice is essential before considering this medication.
What if you forget to take Fenabrate 160mg Tablet :
Should you forget a Fenabrate 160mg Tablet dose, take it immediately if possible. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Fenabrate 160mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Fibric acid-derived compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Fibrate drugs (PPARα agonists) |
